ATB Therapeutics is a Biotech company developing a cutting-edge technology to produce a new kind of targeted therapy designed to treat cancers and auto-immune diseases. ATB Therapeutics has two Belgian R&D sites located in the Novalis Science Park (Marche-en-Famenne) and the VIB incubator (Ghent).
The company closed a successful Series A financing round of Euro 54 million in November 2024, and is backed by leading European and US investors.
To support our growing team, we are looking for a Manager Financial Planning & Accounting to join us in Ghent, helping us to smoothly run our finance processes.
We are looking for a great, enthusiastic team player with an eye for detail and a knack for numbers.
As Manager Financial Planning & Accounting at ATB Therapeutics, you will be responsible for the full accounting cycle and play a hands-on role in Financial Planning & Analysis (FP&A). You will act as a finance business partner to management, providing forward-looking financial insights, supporting strategic decision-making, and helping professionalize finance processes in a scaling, R&D-driven environment. This role combines strong accounting ownership with increasing FP&A exposure and is ideal for someone who enjoys building structure while remaining operationally involved. This role will gradually take on broader finance responsibilities as the company scales toward Series B and beyond.
This position is ideal for a professional with strong analytical skills and experience in a dynamic, international environment.
This is what you will be working on:
-
Oversee the full accounting cycle, including Accounts Payable, Accounts Receivable, and General Ledger.
- Manage month-end and year-end closing activities, including balance sheet reconciliations and statutory reporting.
- Prepare and review financial statements in compliance with IFRS and local GAAP.
- Develop, implement, and maintain accounting policies, procedures, and internal controls appropriate for a scaling biotech.
- Coordinate with external auditors, tax advisors, and other external stakeholders.
- Support ERP implementation, process automation, and data quality improvements.
- Lead and further develop the budgeting and forecasting process, including scenario planning (base / upside / downside).
- Prepare management reporting, dashboards, and KPIs tailored to a biotech/R&D context (cash burn, runway, project spend, headcount).
- Monitor actuals vs. budget and provide variance analysis with clear explanations and actionable insights.
- Support cash flow forecasting, cash runway analysis, and funding preparation (Series B readiness).
- Partner closely with R&D, operations, and leadership to support resource allocation and investment decisions.
- Contribute to long-term financial planning, including capacity scaling and organizational growth.
For a successful fulfilment of this position, we are interested in candidates meeting the following requirements:
-
Bachelor’s or master’s degree in Finance, Accounting, or Economics.
- Minimum 4–6 years of relevant experience in accounting, audit, or FP&A; experience in a scale-up, biotech, or R&D-driven environment is a strong asset.
- Solid grounding in accounting principles and financial reporting combined with strong analytical skills.
- Demonstrated experience with budgeting, forecasting, and management reporting.
- Hands-on experience with ERP systems (e.g. SAP, Oracle, NetSuite) and implementation or optimization projects.
- Advanced Excel skills; familiarity with BI or automation tools is a plus.
- Ability to translate financial data into clear messages for non-financial stakeholders.
- Proactive, structured, and comfortable operating in a fast-growing, evolving organization.
- Fluent in English; experience with multi-currency, VAT/GST, and international operations is a plus.
Besides becoming part of a driven and growing, close-knit team, we offer a competitive salary with 32 holidays, a permanent contract, health insurance and meal vouchers, as well as several fun team events per year.
Founded in 2018, ATB Therapeutics is a pioneering biotechnology company dedicated to the discovery and development of novel antibody therapies. Leveraging a proprietary technology platform based on plant molecular farming, ATB Therapeutics aims to deliver targeted solutions to high unmet medical needs, including oncology and autoimmune diseases, through innovative, next-generation weaponized antibody treatments.